PAX5 and acute lymphoblastic leukemia: In a reported study of a murine model, transgenic RNAi was used to reversibly suppress endogenous PAX5, which cooperates with an activated signal transducer and activator of transcription 5 (STAT5) to induce B-ALL [14].